The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines ...

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a ...

The site at Ulverston currently belongs to GlaxoSmithKline (GSK), which ... to establish the area as a "nationally-advanced manufacturing location". The proposals include "flexible office space ...